brain neoplasm: A neoplasm (disease) that involves the brain.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
250 |
4. Check minimum number of eventsNone |
250 |
5. Include endpointsNone |
250 |
6. Filter based on genotype QC (FinnGen only) |
227 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D31
- Name in latin
- Neoplasma benignum orbitae non specificatum
Similar endpoints
↥List of similar endpoints to
Benign neoplasm: Orbit, unspecified
based on the number of shared cases.
Similar with more cases:
- Benign neoplasm of eye and adnexa
- Benign neoplasms
- Neoplasms
- Any prescribed medicine buy
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 1703 | 988 | 701 |
| Only index persons | 1480 | 873 | 607 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.02 | 0.03 | 0.02 |
| Only index persons | 0.03 | 0.03 | 0.02 |
| Median age at first event (years) | |||
| Whole population | 50.29 | 50.56 | 49.71 |
| Only index persons | 49.65 | 50.35 | 48.65 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 227 | 150 | 77 |
| Unadjusted period prevalence (%) | 0.05 | 0.05 | 0.04 |
| Median age at first event (years) | 54.91 | 53.08 | 58.46 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 234
- Matched controls
- 2340
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D31.6
ICD-10 Finland
Benign neoplasm: Orbit, unspecified
+∞
272.1
205
*
CA1CG
NOMESCO Finland
Eye and orbita extensive MRI examination with high intensity magnet
300.2
49.0
48
*
CAA30
NOMESCO Finland
Biopsy of orbit
+∞
39.7
37
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
5.6
22.5
49
106
CAB00
NOMESCO Finland
Anterior orbitotomy with excision of lesion
+∞
20.1
19
*
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
8.6
20.0
27
35
H05.2
ICD-10 Finland
Exophthalmic conditions
114.8
19.9
21
*
CA1CM
NOMESCO Finland
Eye and orbita extensive MRI examination with 3 Tesla magnet
+∞
17.9
17
*
22405
ICD-8 Finland
Benign neoplasm of eye, Orbitae
+∞
16.9
16
*
2241A
ICD-9 Finland
Benign neoplasm of eye, Orbit
+∞
16.9
16
*
D23.1
ICD-10 Finland
Benign neoplasm: Skin of eyelid, including canthus
7.8
16.4
24
34
Z01.0
ICD-10 Finland
Examination of eyes and vision
3.5
16.2
74
275
XCK00
NOMESCO Finland
Perimetry
5.0
14.6
34
77
D31.0
ICD-10 Finland
Benign neoplasm: Conjunctiva
36.5
13.7
17
5
CA1BG
NOMESCO Finland
Eye and orbita MRI examination with high intensity magnet
36.5
13.7
17
5
CA1DG
NOMESCO Finland
Eye and orbita very extensive MRI examination with high intensity magnet
+∞
13.7
13
*
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
2.6
11.9
132
771
CAB10
NOMESCO Finland
Lateral orbitotomy with excision of lesion
+∞
11.5
11
*
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
4.5
11.5
30
74
H05.9
ICD-10 Finland
Disorder of orbit, unspecified
+∞
10.5
10
*
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
14.0
10.3
17
13
D48.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other specified sites
27.4
9.9
13
5
XCK10
NOMESCO Finland
Photography of fundus of eye
3.4
9.6
38
126
C83.80
ICD-10 Finland
B-cell lymphoma in marginal zone
104.1
9.5
10
*
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.8
9.3
56
237
H57.1
ICD-10 Finland
Ocular pain
4.7
9.1
22
51
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.3
8.8
131
835
AAB10
NOMESCO Finland
Partial excision of intracranial lesion
17.1
8.7
13
8
D32.02
ICD-10 Finland
Benign tumor of the meninges at the base of the brain
13.4
8.5
14
11
C69.60
ICD-10 Finland
Malignant tumor in orbit without histology
93.3
8.5
9
*
H05.1
ICD-10 Finland
Chronic inflammatory disorders of orbit
+∞
8.4
8
*
ZXD10
NOMESCO Finland
Scheduled procedure
2.3
8.3
103
605
CS494
NOMESCO Finland
Other visual field testing
7.3
8.3
19
28
D32.00
ICD-10 Finland
Benign tumor of the meninges on the outer surface of the cerebrum
13.7
8.0
13
10
H04.10
ICD-10 Finland
Dry eye syndrome
2.8
7.7
43
174
WX408
NOMESCO Finland
General anesthesy, balanced
2.3
7.6
74
390
C69.63
ICD-10 Finland
Malignant tumor of orbital carcinoma
+∞
7.3
7
*
9699/3-C69.6
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of orbit, NOS
+∞
7.3
7
*
WX002
NOMESCO Finland
Sedation and analgesia
2.4
7.3
59
286
AA1AD
NOMESCO Finland
CT of head and brain
2.2
7.1
88
511
ZXE10
NOMESCO Finland
More than one and less than three hours
2.1
7.0
97
586
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
2.8
6.9
37
146
CFA20
NOMESCO Finland
Biopsy of conjunctiva
41.3
6.8
8
*
D36.1
ICD-10 Finland
Benign neoplasm: Peripheral nerves and autonomic nervous system
23.3
6.7
9
*
XW000
NOMESCO Finland
Bone marrow biopsy
4.3
6.5
17
42
D31.5
ICD-10 Finland
Benign neoplasm: Lacrimal gland and duct
+∞
6.3
6
*
XCD10
NOMESCO Finland
Electrophysiological examination of eye
6.3
6.1
15
25
H53.2
ICD-10 Finland
Diplopia
4.2
6.0
16
40
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
49
229
2.44
6.54
4.7
5.0
210.02
253.15
u/l
3.28
49
215
160
1196
2.07
6.19
10.2
9.6
4.13
4.09
e9/l
0.08
132
1054
131
940
1.89
5.39
6.9
6.8
1.21
1.21
mmol/l
0.50
124
867
184
1531
1.94
4.22
4.5
4.3
12.65
11.67
mm/h
0.46
173
1412
93
637
1.76
4.15
1.7
1.7
22.60
21.73
nmol/l
0.18
83
528
222
1994
3.21
4.15
19.5
16.2
22.46
22.86
mg/l
0.06
194
1629
134
1030
1.70
3.86
8.3
7.7
1.21
1.21
mmol/l
0.04
122
893
28
129
2.33
3.82
1.4
1.3
11.90
24.39
au/ml
—
5
11
143
1126
1.69
3.70
5.3
4.2
0.00
6.60
estimate
0.50
18
246
30
145
2.23
3.67
2.7
2.5
29.26
9.99
au/ml
—
5
9
144
1143
1.68
3.55
5.4
4.3
0.00
0.00
estimate
-0.00
18
233
88
621
1.67
3.39
3.8
3.1
0.27
0.52
e6/l
0.93
53
452
74
502
1.69
3.30
2.6
2.4
—
—
—
0
0
140
1118
1.63
3.25
5.3
4.2
0.00
0.00
estimate
-0.00
18
243
119
918
1.60
3.15
6.6
4.9
36.42
35.83
g/l
0.66
112
864
122
948
1.60
3.12
2.4
2.1
95.37
96.97
pmol/l
0.15
70
472
58
376
1.72
3.02
4.2
2.7
0.45
1.03
e6/l
1.73
22
203
12
37
3.36
2.98
1.2
1.2
2.00
4.29
u/ml
—
7
17
31
166
2.00
2.93
3.6
2.5
71.53
62.71
ml/min/173m2
0.73
15
75
209
1882
2.03
2.91
6.6
5.4
1.81
1.91
mu/l
0.49
199
1735
41
243
1.83
2.88
7.5
10.5
0.75
1.00
mmol/l
0.14
34
207
225
2109
2.74
2.87
25.5
21.0
77.71
75.40
umol/l
0.42
225
2086
8
18
4.56
2.82
1.1
1.1
—
—
—
0
0
15
62
2.52
2.60
2.0
2.5
—
—
—
0
0
97
738
1.54
2.59
4.7
3.3
2.34
2.36
mmol/l
0.64
87
665
12
44
2.82
2.59
1.4
1.3
—
—
—
0
0
53
350
1.66
2.56
3.7
2.9
4.61
2.69
e6/l
0.28
17
177
212
1942
1.97
2.44
5.2
5.0
5.88
5.91
mmol/l
0.13
193
1783
220
2043
2.28
2.42
23.1
19.4
3.96
3.96
mmol/l
0.05
220
1998
101
785
1.50
2.40
4.2
3.1
—
—
—
0
0
6
13
4.71
2.28
1.7
1.8
—
—
—
0
0
27
151
1.89
2.28
1.7
1.6
—
—
—
0
0
180
1587
1.58
2.28
5.4
4.4
14.71
14.84
pmol/l
0.30
172
1442
219
2039
2.16
2.24
23.0
19.3
139.60
139.66
mmol/l
0.14
219
1998
5
9
5.65
2.22
1.0
1.6
—
—
—
0
0
5
9
5.65
2.22
4.6
2.4
533.20
896.11
u/ml
—
5
9
5
9
5.65
2.22
2.4
1.6
—
—
—
0
0
23
123
1.96
2.21
2.4
1.8
—
—
—
0
0
51
348
1.60
2.15
2.2
2.0
—
—
—
0
0
51
348
1.60
2.15
3.1
3.4
0.82
0.82
mmol/l
0.12
45
328
40
257
1.67
2.14
2.3
1.8
—
—
—
0
0
119
977
1.44
2.05
3.1
2.9
—
—
estimate
—
0
0
188
1688
1.58
2.05
22.5
20.1
13.65
13.63
%
0.08
188
1671
209
1927
1.79
2.05
18.3
15.9
82.17
81.05
ml/min/173m2
0.30
189
1782
74
555
1.49
2.04
2.6
2.1
2.68
2.81
mg/l
0.27
62
485
203
1859
1.69
2.01
4.3
4.3
1.32
1.26
mmol/l
0.57
183
1707
177
1571
1.52
2.01
9.5
8.1
75.43
78.15
u/l
0.43
171
1491
227
2168
2.57
2.00
30.5
24.4
133.44
134.28
g/l
0.41
227
2148
227
2166
2.60
2.00
31.2
24.8
39.82
40.17
%
0.44
227
2146
227
2166
2.60
2.00
30.3
24.3
4.45
4.46
e12/l
0.14
221
2122
227
2166
2.60
2.00
30.3
24.2
90.78
91.15
fl
0.64
227
2147
211
1957
1.80
1.93
5.2
5.1
1.46
1.49
mmol/l
0.43
196
1810
12
52
2.38
1.91
1.1
1.3
—
1.00
—
0
6
7
22
3.25
1.89
1.3
1.1
—
—
—
0
0
37
245
1.61
1.77
2.4
1.9
—
—
—
0
0
57
417
1.49
1.75
5.0
4.0
20.36
315.46
ng/l
2.23
42
336
64
480
1.46
1.74
2.7
1.8
1.21
1.34
mg/l
0.11
50
374
185
1678
1.49
1.69
26.9
20.5
332.34
331.89
g/l
0.30
185
1671
16
83
2.00
1.69
3.3
2.3
2.96
2.85
g/l
0.15
16
76
14
69
2.09
1.68
1.1
1.3
—
—
—
0
0
11
49
2.31
1.66
1.0
1.3
—
40.43
—
0
7
12
56
2.20
1.64
1.2
1.3
—
—
—
0
0
213
2000
1.72
1.59
6.3
5.9
2.73
2.70
mmol/l
0.15
201
1849
210
1968
1.65
1.54
5.3
5.2
4.66
4.64
mmol/l
0.13
198
1827
155
1373
1.38
1.53
3.2
3.4
35.99
46.10
u/l
2.01
148
1302
9
38
2.42
1.47
1.0
1.2
—
—
—
0
0
202
1881
1.54
1.47
6.7
6.4
38.98
39.21
mmol/mol
0.15
193
1769
42
301
1.48
1.43
7.6
7.1
105.29
104.24
mmol/l
0.94
42
301
23
143
1.67
1.41
2.7
2.7
8.20
13.32
nmol/l
1.97
18
132
16
89
1.86
1.41
3.3
2.2
7.29
7.38
g/l
0.07
16
82
16
89
1.86
1.41
3.3
2.2
3.37
3.46
g/l
0.16
16
82
16
89
1.86
1.41
3.3
2.2
4.05
4.47
g/l
0.88
16
82
51
382
1.43
1.38
1.4
1.3
15.29
34.02
iu/ml
1.89
14
107
6
23
2.65
1.37
1.0
1.1
—
—
—
0
0
47
349
1.43
1.34
1.3
1.3
1.22
9.92
u/ml
2.43
14
131
9
43
2.14
1.32
1.3
1.3
—
—
—
0
0
9
43
2.14
1.32
1.3
1.3
—
—
—
0
0
13
69
1.94
1.31
2.2
1.6
—
—
—
0
0
6
24
2.54
1.31
1.8
1.2
369.33
293.79
mu/l
—
6
19
6
24
2.54
1.31
1.0
1.1
—
—
—
0
0
6
24
2.54
1.31
1.0
1.1
—
—
—
0
0
6
24
2.54
1.31
1.0
1.2
—
—
—
0
0
32
223
1.50
1.25
2.2
2.1
—
—
—
0
0
6
25
2.44
1.25
1.0
1.2
—
—
—
0
0
47
355
1.41
1.22
3.2
2.4
12.86
13.34
umol/l
0.17
42
333
14
79
1.82
1.20
2.8
2.2
9.92
9.68
g/l
0.10
14
71
8
38
2.14
1.19
1.3
1.1
—
—
—
0
0
82
679
1.32
1.19
3.9
3.9
9.79
10.14
mg/mmol
0.02
45
418
57
447
1.36
1.19
4.1
2.6
2.45
2.45
mmol/l
0.04
51
396
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
10
50
2.04
1.18
3.3
2.3
0.33
0.34
iu/ml
—
5
23
141
1261
1.30
1.14
3.5
3.1
—
—
—
0
0
7
30
2.37
1.13
1.1
1.2
—
—
—
0
0
13
73
1.83
1.13
1.5
1.5
358.37
217.25
miu/ml
—
6
36
31
221
1.46
1.10
10.1
7.0
—
—
—
0
0
5
21
2.41
1.09
1.0
1.1
—
—
—
0
0
51
399
1.36
1.08
1.5
1.6
—
—
—
0
0
13
75
1.78
1.05
1.5
1.9
801.15
309.93
ug/l
0.48
13
69
20
131
1.58
1.04
6.6
7.6
24.50
24.85
mmol/l
0.17
20
131
29
207
1.46
1.03
4.1
2.6
37.58
29.15
u/l
0.55
24
172
34
253
1.40
0.97
2.5
2.2
—
—
—
0
0
6
27
2.25
0.94
1.0
1.1
—
—
—
0
0
9
52
1.76
0.93
1.2
1.5
—
—
—
0
0
6
29
2.10
0.90
1.0
1.5
—
—
—
0
0
109
964
1.24
0.89
2.2
2.5
76.98
77.14
nmol/l
0.02
97
862
78
665
1.26
0.88
3.5
3.4
1062.43
1406.99
ng/l
0.54
65
563
11
64
1.75
0.87
4.0
5.8
45.48
23.33
mg/l
0.58
11
54
11
64
1.75
0.87
4.0
5.7
67.57
59.47
mg/l
0.10
11
54
60
496
1.28
0.87
6.9
4.6
1.02
1.02
kg/l
0.24
40
330
11
66
1.70
0.80
1.4
1.2
—
—
—
0
0
12
74
1.66
0.80
3.3
2.2
1150.92
7560.05
u/l
—
6
23
8
48
1.69
0.79
1.1
1.2
3.30
3.77
mmol/l
—
8
43
6
34
1.78
0.77
1.2
1.3
—
—
—
0
0
5
24
2.11
0.75
1.0
1.2
—
—
—
0
0
28
212
1.36
0.74
4.1
4.2
2.22
39.46
ug/l
0.60
21
173
5
25
2.02
0.73
1.2
1.6
—
—
—
0
0
92
814
1.21
0.72
4.5
4.0
20.16
42.13
ng/l
2.35
66
585
22
161
1.40
0.71
1.6
1.4
—
—
—
0
0
5
27
1.87
0.69
1.0
1.5
—
—
—
0
0
5
27
1.87
0.69
1.0
1.5
—
—
—
0
0
43
353
1.27
0.66
1.6
1.6
1142.72
1200.00
nmol/l
0.16
33
263
5
28
1.80
0.66
1.0
1.5
—
—
—
0
0
5
28
1.80
0.66
1.0
1.5
—
—
—
0
0
18
129
1.43
0.65
2.3
2.4
0.73
0.60
%
0.73
18
129
5
29
1.74
0.64
1.0
1.5
—
—
—
0
0
5
29
1.74
0.64
1.0
1.0
—
2.07
—
0
7
9
59
1.55
0.55
1.1
1.3
—
—
—
0
0
6
38
1.59
0.54
1.5
1.8
—
—
—
0
0
10
66
1.54
0.53
1.7
1.3
—
—
—
0
0
10
66
1.54
0.53
3.6
2.8
1.38
1.49
mg/l
—
10
57
9
65
1.40
0.51
1.6
1.4
—
—
—
0
0
7
45
1.57
0.49
1.3
1.2
—
—
—
0
0
10
68
1.49
0.47
1.6
1.2
—
—
—
0
0
7
50
1.41
0.45
1.1
1.9
—
—
—
0
0
17
131
1.32
0.43
2.4
2.4
1.29
1.15
%
0.41
17
131
5
31
1.63
0.43
2.0
1.5
0.37
0.48
nmol/l
—
5
23
0
16
0.00
0.41
0.0
1.9
—
13.59
—
0
16
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
5
34
1.48
0.40
1.0
1.1
—
—
—
0
0
14
106
1.34
0.40
1.1
1.3
—
—
—
0
0
28
235
1.22
0.38
1.5
1.7
1.40
1.49
%
0.30
23
207
5
37
1.36
0.37
1.6
1.2
13.08
22.72
u/l
—
5
32
30
256
1.20
0.35
4.9
4.8
30.21
31.80
%
0.39
19
164
37
327
1.16
0.30
3.0
3.3
0.90
0.79
ug/l
0.25
26
212
7
56
1.26
0.29
1.0
1.2
—
—
—
0
0
7
57
1.23
0.29
1.0
1.2
—
—
—
0
0
8
64
1.26
0.28
1.4
1.4
—
—
—
0
0
47
429
1.12
0.25
1.5
1.7
410.31
450.29
pmol/l
0.52
39
353
9
77
1.18
0.24
1.6
2.0
—
—
—
0
0
6
85
0.70
0.24
6.3
1.8
1.33
3.77
mg/l
—
6
63
16
134
1.21
0.23
1.3
1.3
50.70
352.36
u/ml
1.61
16
124
59
634
0.91
0.23
3.7
3.6
0.00
0.00
estimate
-0.00
17
192
5
40
1.26
0.22
1.6
1.5
—
—
—
0
0
0
11
0.00
0.21
0.0
1.8
—
—
—
0
0
0
11
0.00
0.21
0.0
1.8
—
—
—
0
0
0
11
0.00
0.21
0.0
1.8
—
—
—
0
0
0
11
0.00
0.21
0.0
1.8
—
—
—
0
0
0
11
0.00
0.21
0.0
4.3
—
228.00
—
0
11
0
12
0.00
0.21
0.0
2.0
—
50.02
—
0
12
0
12
0.00
0.21
0.0
3.5
—
4.60
—
0
12
0
12
0.00
0.21
0.0
3.5
—
10.87
—
0
12
5
43
1.17
0.21
1.4
1.7
—
—
—
0
0
0
14
0.00
0.20
0.0
3.4
—
1.07
—
0
14
46
428
1.09
0.17
4.2
4.7
22.82
21.12
%
0.25
20
208
91
872
1.07
0.17
6.0
4.1
0.20
0.02
estimate
0.42
15
202
9
79
1.14
0.15
1.4
2.1
—
—
—
0
0
24
217
1.12
0.15
2.1
3.3
—
—
—
0
0
91
877
1.06
0.14
2.2
2.0
1.36
1.34
mmol/l
0.11
78
730
14
122
1.16
0.14
2.4
2.0
—
—
—
0
0
10
117
0.85
0.13
1.2
1.0
—
—
—
0
0
61
639
0.94
0.13
7.6
4.3
0.00
0.01
estimate
0.50
17
225
5
47
1.07
0.09
1.2
1.4
—
—
—
0
0
6
54
1.11
0.09
1.2
1.5
—
—
—
0
0
52
502
1.05
0.07
1.3
1.3
0.92
0.94
u/ml
—
9
125
12
112
1.08
0.03
1.3
1.3
—
—
—
0
0
35
351
1.00
0.00
1.4
1.5
—
—
—
0
0
14
145
0.96
0.00
3.1
2.1
—
—
—
0
0
5
53
0.94
0.00
1.2
1.4
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.5
—
—
—
0
0
6
63
0.95
-0.00
1.3
1.2
1.64
1.57
g/l
—
6
63
0
8
0.00
-0.00
0.0
1.9
—
—
—
0
0
0
7
0.00
-0.00
0.0
9.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.7
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
60.47
—
0
7
0
8
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.9
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.6
—
—
—
0
0
6
63
0.95
-0.00
1.3
1.2
0.82
0.89
g/l
—
6
63
0
7
0.00
-0.00
0.0
2.7
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
7.29
—
0
7
0
8
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
87.60
—
0
5
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
6
61
0.98
-0.00
1.2
1.5
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.6
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint CD2_BENIGN_ORBIT_NOS and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_BENIGN_ORBIT_NOS | 1.274 [1.0, 1.63] | 0.051 |
| Birth year | 0.99 [0.98, 1.0] | 0.051 |
During the follow-up period (1.1.1998 — 31.12.2019), 108 out of 648 females with CD2_BENIGN_ORBIT_NOS died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_BENIGN_ORBIT_NOS | 1.337 [1.0, 1.79] | 0.053 |
| Birth year | 0.984 [0.97, 0.99] | 0.001 |
During the follow-up period (1.1.1998 — 31.12.2019), 90 out of 444 males with CD2_BENIGN_ORBIT_NOS died.
Mortality risk
Mortality risk for people of age
years, who have CD2_BENIGN_ORBIT_NOS.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.107% | 0.224% |
| 5 | 0.624% | 1.468% |
| 10 | 1.459% | 3.587% |
| 15 | 2.954% | 6.69% |
| 20 | 5.353% | 11.526% |
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_ORBIT_NOS – Benign neoplasm: Orbit, unspecified
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data